Cargando…

Macrophages as Promising Carriers for Nanoparticle Delivery in Anticancer Therapy

Macrophages play a critical role in the immune response due to their ability to recognize and remove pathogens, as well as present antigens, which are involved in inflammation, but they are also one of the most abundant immune cell populations present in the tumor microenvironment. In recent years,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wróblewska, Anna, Szczygieł, Agnieszka, Szermer-Olearnik, Bożena, Pajtasz-Piasecka, Elżbieta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422973/ https://www.ncbi.nlm.nih.gov/pubmed/37576466 http://dx.doi.org/10.2147/IJN.S421173

Ejemplares similares

Boron-Rich Boron Carbide Nanoparticles as a Carrier in Boron Neutron Capture Therapy: Their Influence on Tumor and Immune Phagocytic Cells
por: Kozień, Dawid, et al.
Publicado: (2021)

Synthesis and Characterization of Boron Carbide Nanoparticles as Potential Boron-Rich Therapeutic Carriers
por: Kozień, Dawid, et al.
Publicado: (2023)

Inhibition of MC38 colon cancer growth by multicomponent chemoimmunotherapy with anti-IL-10R antibodies, HES-MTX nanoconjugate, depends on application of IL-12, IL-15 or IL-18 secreting dendritic cell vaccines
por: Węgierek-Ciura, Katarzyna, et al.
Publicado: (2023)

Combined therapy with methotrexate nanoconjugate and dendritic cells with downregulated IL-10R expression modulates the tumor microenvironment and enhances the systemic anti-tumor immune response in MC38 murine colon carcinoma
por: Szczygieł, Agnieszka, et al.
Publicado: (2023)

Antitumor Potential of Extracellular Vesicles Released by Genetically Modified Murine Colon Carcinoma Cells With Overexpression of Interleukin-12 and shRNA for TGF-β1
por: Rossowska, Joanna, et al.
Publicado: (2019)

The Beneficial Effect of IL-12 and IL-18 Transduced Dendritic Cells Stimulated with Tumor Antigens on Generation of an Antitumor Response in a Mouse Colon Carcinoma Model
por: Mierzejewska, Jagoda, et al.
Publicado: (2022)

Intratumoral Lentivector-Mediated TGF-β1 Gene Downregulation As a Potent Strategy for Enhancing the Antitumor Effect of Therapy Composed of Cyclophosphamide and Dendritic Cells
por: Rossowska, Joanna, et al.
Publicado: (2017)

Immunomodulatory potential of anticancer therapy composed of methotrexate nanoconjugate and dendritic cell-based vaccines in murine colon carcinoma
por: Szczygieł, Agnieszka, et al.
Publicado: (2021)

Reprogramming the murine colon cancer microenvironment using lentivectors encoding shRNA against IL-10 as a component of a potent DC-based chemoimmunotherapy
por: Rossowska, Joanna, et al.
Publicado: (2018)

Removal of Endotoxins from Bacteriophage Preparations by Extraction with Organic Solvents
por: Szermer-Olearnik, Bożena, et al.
Publicado: (2015)

Treatment with cyclophosphamide supported by various dendritic cell-based vaccines induces diversification in CD4(+) T cell response against MC38 colon carcinoma
por: WOJAS-TUREK, JUSTYNA, et al.
Publicado: (2015)

Bacteriophage Tail Proteins as a Tool for Bacterial Pathogen Recognition—A Literature Review
por: Filik, Karolina, et al.
Publicado: (2022)

Treatment with lentiviral vectors encoding shRNA against interleukin 10 modulates the immunosuppressive activity of murine colon carcinoma-associated myeloid-derived suppressor cells
por: Anger-Góra, Natalia, et al.
Publicado: (2021)

New Insights on the Feature and Function of Tail Tubular Protein B and Tail Fiber Protein of the Lytic Bacteriophage φYeO3-12 Specific for Yersinia enterocolitica Serotype O:3
por: Pyra, Anna, et al.
Publicado: (2020)

Enabling Anticancer Therapeutics by Nanoparticle Carriers: The Delivery of Paclitaxel
por: Liu, Yongjin, et al.
Publicado: (2011)

φYeO3-12 phage tail fiber Gp17 as a promising high specific tool for recognition of Yersinia enterocolitica pathogenic serotype O:3
por: Filik, Karolina, et al.
Publicado: (2022)

Oral Administration of Polymyxin B Modulates the Activity of Lipooligosaccharide E. coli B against Lung Metastases in Murine Tumor Models
por: Kicielińska, Jagoda, et al.
Publicado: (2016)

Lipid Nanoparticles as a Promising Drug Delivery Carrier for Topical Ocular Therapy—An Overview on Recent Advances
por: Jacob, Shery, et al.
Publicado: (2022)

Pillararenes as Promising Carriers for Drug Delivery
por: Zyryanov, Grigory V., et al.
Publicado: (2023)

The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy
por: Puris, Elena, et al.
Publicado: (2023)

Aggregation/dispersion transitions of T4 phage triggered by environmental ion availability
por: Szermer-Olearnik, Bożena, et al.
Publicado: (2017)

Polymeric nanoparticles—Promising carriers for cancer therapy
por: Xiao, Xiao, et al.
Publicado: (2022)

Typical and Atypical Inducers of Lysosomal Cell Death: A Promising Anticancer Strategy
por: Domagala, Antoni, et al.
Publicado: (2018)

Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy
por: Lohcharoenkal, Warangkana, et al.
Publicado: (2014)

The specific T-cell response to antigenic peptides is influenced by bystander peptides
por: Nowak, Izabela, et al.
Publicado: (2006)

Primary M1 macrophages as multifunctional carrier combined with PLGA nanoparticle delivering anticancer drug for efficient glioma therapy
por: Pang, Liang, et al.
Publicado: (2018)

Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs)
por: Huttunen, Johanna, et al.
Publicado: (2022)

Polyethyleneimine-Based Lipopolyplexes as Carriers in Anticancer Gene Therapies
por: Jerzykiewicz, Julia, et al.
Publicado: (2021)

Tumor Microenvironment-Responsive Nanomaterials as Targeted Delivery Carriers for Photodynamic Anticancer Therapy
por: Liu, Houhe, et al.
Publicado: (2020)

Bacterial outer membrane vesicles as drug delivery carrier for photodynamic anticancer therapy
por: Jiang, Yuan, et al.
Publicado: (2023)

Nanoformulations for Delivery of Pentacyclic Triterpenoids in Anticancer Therapies
por: Kaps, Anna, et al.
Publicado: (2021)

Silver Nanoparticles as Carriers of Anticancer Drugs for Efficient Target Treatment of Cancer Cells
por: Gomes, Helena I. O., et al.
Publicado: (2021)

Silver Nanoparticles Surface-Modified with Carbosilane Dendrons as Carriers of Anticancer siRNA
por: Pędziwiatr-Werbicka, Elżbieta, et al.
Publicado: (2020)

Lipid Nanoparticles as Promising Carriers for mRNA Vaccines for Viral Lung Infections
por: Hajiaghapour Asr, Mena, et al.
Publicado: (2023)

Metal and Metal Oxide Nanoparticle as a Novel Antibiotic Carrier for the Direct Delivery of Antibiotics
por: Kotrange, Harshada, et al.
Publicado: (2021)

Hydrogels as promising carriers for the delivery of food bioactive ingredients
por: Li, Min, et al.
Publicado: (2022)

The role of immune cell subpopulations in the growth and rejection of TC-1/A9 tumors in novel mouse strains differing in the H2-D haplotype and NKC domain
por: Indrová, Marie, et al.
Publicado: (2018)

Delivery of Natural Agents by Means of Mesoporous Silica Nanospheres as a Promising Anticancer Strategy
por: AbouAitah, Khaled, et al.
Publicado: (2021)

The interaction of anticancer therapies with tumor-associated macrophages
por: Mantovani, Alberto, et al.
Publicado: (2015)

A Comprehensive Review on Cyclodextrin-Based Carriers for Delivery of Chemotherapeutic Cytotoxic Anticancer Drugs
por: Gidwani, Bina, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0pb9h42o6kislmkbd7m3uit98g